pollution and mask

Asthma and pollution: why personal monitoring can change clinical perspective

By

In recent years, research in pulmonology has begun to challenge a traditional concept: the notion that exposure to air pollutants can be adequately represented by data from ambient air quality monitoring stations. Recent studies suggest, however, that an individual’s actual exposure is far more complex and variable, and that personalised measurement can provide more accurate and clinically relevant information, particularly in patients with moderate-to-severe asthma.
The limitations of traditional environmental monitoring

Air quality monitoring stations provide essential data at the epidemiological and public health levels. However, these systems have certain limitations:

  1. they measure air quality at specific locations;
  2. they do not reflect individual variations in exposure;
  3. they do not take into account a person’s daily activities;
  4. they do not account for indoor environments.

Consequently, the concentration of pollutants measured at an urban level may differ significantly from that actually inhaled by an individual.

The new approach: personal exposure monitoring

Digital technologies have made possible an innovative approach based on personal exposure monitoring.

Using portable devices and wearable sensors, it is now possible to collect real-time data on:

  • pollutant concentrations (PM2.5, NO₂, etc.);
  • patient location;
  • daily activities;
  • respiratory parameters.

This data can be integrated with:

  • home spirometry;
  • symptom questionnaires;
  • digital applications for clinical monitoring.
What recent studies show

Prospective studies conducted on patients with asthma have demonstrated that:

  • individual exposure to pollutants can vary significantly from average environmental data;
  • exposure peaks are often linked to specific daily activities (e.g. traffic, indoor environments, kitchens);
  • there is a correlation between acute exposures and worsening of respiratory symptoms.

These findings suggest that respiratory risk is not constant, but dynamic and personalised.

Implications for asthma management

Personal exposure monitoring opens up new possibilities in asthma management.

Key benefits include:

Identification of individual triggers

Each patient may be exposed to different factors, often undetectable by traditional systems.

Prevention of exacerbations

Recognising periods of heightened exposure allows for the adoption of preventive strategies.

Personalisation of treatment

The therapeutic approach can be adapted not only to the disease, but also to the environment in which the patient lives.

Towards precision pulmonology

These developments are part of a broader shift in respiratory medicine, which is moving towards precision pulmonology.

In this new paradigm:

  • the disease is no longer viewed in a uniform manner;
  • the environment becomes an integral part of clinical assessment;
  • digital data enables continuous and personalised monitoring.

This approach is particularly relevant in chronic diseases such as asthma, which are characterised by significant individual variability.

Future challenges

Despite its great potential, personal monitoring still presents some challenges:

  • the need for large-scale clinical validation;
  • integration of data into clinical practice;
  • management and interpretation of large amounts of data;
  • accessibility of technologies.

However, these tools are likely to become increasingly widespread in the coming years.

The shift from a model based on average environmental data to an individual-centred approach represents a significant change in respiratory medicine. Personal monitoring allows for a better understanding of the relationship between exposure and symptoms, paving the way for more effective treatment strategies.

Personal monitoring of exposure to pollutants represents one of the most promising innovations in asthma management.

Understanding what the patient actually breathes in, and at what times, allows for more targeted intervention, improving disease control and quality of life.

The pulmonology of the future will increasingly be a personalised, dynamic and, above all, environmentally integrated medicine.